Ensysce Biosciences, Inc. [ENSC] - Ensysce Biosciences / Cy Biopharma merger
Ensysce Biosciences, Inc. acquired Cy Biopharma, Inc. in a tax-free reorganization, issuing 282,122 shares of Series C Preferred Stock to Cy's equityholders upon closing on August 5, 2026.
Why this matters
Generating analysis…